Results 61 to 70 of about 87,506 (306)

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

open access: yesArthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr   +5 more
wiley   +1 more source

Activating the Legal Framework for Electronic Signatures to Establish a Digital Economy in Algeria

open access: yesمجلة القانون، المجتمع والسلطة
Algeria has kept pace with global technological developments regarding electronic signatures and has enacted a legal framework to regulate them, starting with the amendment of the Civil Code in 2005, followed by Law No.
Hazil El-Hadje
doaj   +1 more source

Strong Designated Verifier Signature Scheme with Undeniability and Strong Unforgeability in the Standard Model

open access: yesApplied Sciences, 2019
Strong designated verifier signature can provide an efficient way to protect the identity privacy of the signer and the integrity of the data transmitted over the public channel.
Xiaodong Yang   +5 more
doaj   +1 more source

XML Electronic Signatures [PDF]

open access: yes, 2001
The deployment of electronic signatures becomes vital as an increasing part of business transactions are handled via electronic channels such as the World Wide Web because they facilitate integrity, signature assurance and non-repudiation over electronic data. Extensible Markup Language (XML) has been widely accepted as a generic language for designing
openaire   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

open access: yesArthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya   +4 more
wiley   +1 more source

Usługi zaufania i identyfikacja elektroniczna

open access: yesActa Iuris Stetinensis, 2018
The e-IDAS Regulation is a new European act that comprehensively regulates the issues concerned with trust services and electronic identification. The e-IDAS Regulation broadens the catalogue of trust services, introduces uniform terminology and new ...
Aleksandra Monarcha-Matlak
doaj   +1 more source

Electronic signature law update

open access: yesDigital Evidence and Electronic Signature Law Review, 2022
Avukat Özgür Eralp provides an up-date to the electronic signature laws of Turkey, setting out the full history of electronic signature legislation and recent legislative developments.  Index words: Turkey; electronic signatures; legislation; update 
openaire   +1 more source

Home - About - Disclaimer - Privacy